Eileen Scully, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Investigator

Email:

escully1@jhmi.edu

Dr. Eileen Scully is an assistant professor of medicine at the Johns Hopkins University School of Medicine. 

She received her B.S. from the University of Notre Dame. She earned her Ph.D. and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital.

  • Protocol Chair, ACTG A5366
  • Investigator, Women's Health Inter-Network Scientific Committee (Dec 2017-Nov 2019)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5300/P2003: PHOENIx Feasibility Study

Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Read More

P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate...

This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5253: Sensitivity and Specificity of Mycobacterium...

An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More